NGM-395

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NameNGM-395
Drug Alias NameNGM-395
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGlial cell line-derived neurotrophic factor receptors agonists
TargetsGlial cell line-derived neurotrophic factor receptors
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNGM Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & CoNGM Biopharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A